RXRXRecursion Pharmaceuticals, Inc.
What is the market doing?
No clear lean: in an uptrend, but a crowded short (+30% of shares).
In an uptrend, above its rising 50- and 200-day averages. Price is +3% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 22, 2026; selling is often routine (taxes, diversification).
A crowded short, settled Sep 30, 2026, about a week of normal trading to cover. Down 12% since the previous count, down from 32.2% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How RXRX is trading
Recursion Pharmaceuticals, Inc. is −42% over the past year while the S&P 500 is +16%: 58 points behind the market.
1-year return · S&P 500 +16%
- vs 200-day average
- +3.5%
vs 200-day average · close to trend
- RSI (14)
- 34
RSI (14) · neutral
- Below its 52-week high
- 45%
Below its 52-week high
Details›
- Last close2026-10-23
- $3.70
- 1 monthS&P 500 −0.94%
- −4.9%
- 1 yearS&P 500 +16%
- −42%
- 5 yearsS&P 500 +86%
- −80%
- vs 50-day average$3.66
- +1.1%
- 52-week high
- $6.68
- 52-week low
- $2.84
- Annualised volatility
- 86%
| Year | Return |
|---|---|
| 2026 (year to date) | −9.7% |
| 2025 | −39% |
| 2024 | −31% |
| 2023 | +28% |
| 2022 | −55% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 3 of 5 | −3.6% |
| Feb | 5 | 2 of 5 | +4.9% |
| Mar | 5 | 0 of 5 | −25% |
| Apr | 5 | 2 of 5 | −9.0% |
| May | 6 | 3 of 6 | +7.7% |
| Jun | 6 | 4 of 6 | +12% |
| Jul | 6 | 4 of 6 | +14% |
| Aug | 6 | 2 of 6 | −8.7% |
| Sep | 6 | 3 of 6 | −0.57% |
| Oct | 6 | 1 of 6 | −8.4% |
| Nov | 5 | 2 of 5 | +2.9% |
| Dec | 5 | 1 of 5 | −0.10% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.